Cargando…

495. De novo emergence of resistance mutations during treatment of SARSCoV-2 infection in immunocompromised patients

BACKGROUND: Vaccination and therapeutic strategies for COVID-19 are constantly hindered by the rapid emergence of new viral variants less sensitive to antibodies or antivirals. Emerging evidence points to prolonged replication in the immunocompromised host as a key factor contributing to emergence o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johnson, Katherine, Soave, Rosemary, Wang, Wei, Albert, Joshua, Kodiyanplakkal, Rosy Priya, Salpietro, Maria, Jing-Mei, Hsu, Diel, Diego G, Ghedin, Elodie, Salvatore, Mirella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679207/ http://dx.doi.org/10.1093/ofid/ofad500.564

Ejemplares similares

Is SARSCoV-2 nasopharyngeal swab still a gold standard in children?
por: Marino, Silvia, et al.
Publicado: (2020)

Impact of liver enzymes on SARSCoV-2 infection and on the severity of clinical disease
por: Servín-Caamaño, A., et al.
Publicado: (2020)

Exploring the acceptability of controlled human infection with SARSCoV2—a public consultation
por: Gbesemete, D., et al.
Publicado: (2020)

So much at stake: Ethical tradeoffs in accelerating SARSCoV-2 vaccine development
por: Grady, Christine, et al.
Publicado: (2020)

Aspartate aminotransferase as predictor of severity in SARSCoV-2 infection: linear regression model
por: Servín-Caamaño, A., et al.
Publicado: (2020)

SARSCoV-2 serostatus amongst vaccinated employees at a pediatric hospital system
por: Devaraj, Sridevi, et al.
Publicado: (2021)

Steroid therapy and antiviral treatment in SARSCoV-2 pneumonia: clinical contexts and indications
por: Torres, Antoni, et al.
Publicado: (2022)

Vaccination against SARSCoV-19 among psychiatric patients at the central Greek hospital
por: Anagnostaki, M. E., et al.
Publicado: (2023)

On the case report of Platypnea-orthodeoxia after SARSCoV-2 pneumonia plus historical notes
por: Corrêa, Paulo César Rodrigues Pinto
Publicado: (2020)

Anti-Rheumatic Drugs for the Fight Against the Novel Coronavirus Infection (SARSCoV-2): What is the Evidence?
por: Pelechas, Eleftherios, et al.
Publicado: (2020)

Early Identification of IgA Anti-SARSCoV-2 in Milk of Mother With COVID-19 Infection
por: Lebrão, Cibele Wolf, et al.
Publicado: (2020)

Indian association of medical microbiologists (IAMM) position paper on guidelines for COVID and SARSCoV2 infections
por: Ravi, V., et al.
Publicado: (2023)

Case report of a neonate with high viral SARSCoV-2 loads and long-term virus shedding
por: Slaats, Monique A.L.J., et al.
Publicado: (2020)

Central retinal artery occlusion after vaccination with whole virion inactivated SARSCoV- 2 vaccine Covaxin
por: Thakar, Meenakshi, et al.
Publicado: (2022)

Gastrointestinal tract diseases as a risk factor for SARSCoV2 rectal shedding? An Italian report on 10 COVID-19 patients
por: Patrì, Angela, et al.
Publicado: (2021)

Immune transcriptomes of highly exposed SARSCoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl community
por: Lee, Hye Kyung, et al.
Publicado: (2020)

Nephrotic Syndrome Following ChAdOx1 nCoV-19 Vaccine Against SARScoV-2
por: Anupama, Y.J., et al.
Publicado: (2021)

BNT162b2 induced neutralizing and non-neutralizing antibody functions against SARSCoV-2 diminish with age
por: Bates, Timothy A., et al.
Publicado: (2022)

Evolución temporal de las variantes de SARSCoV-2 circulantes en el área sanitaria de Cádiz
por: Ibañez-López, Cristina, et al.
Publicado: (2023)

The impact of lockdown enforcement during the SARSCoV-2 pandemic on the timing of presentation and early outcomes of patients with ST-elevation myocardial infarction
por: Kobo, Ofer, et al.
Publicado: (2020)

Corrigendum: Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARSCoV-2 Nucleocapsid protein
por: Visvabharathy, Lavanya, et al.
Publicado: (2023)

445 Inflammation in normal COVID-19 airway due to inhibition of cystic fibrosis transmembrane conductance regulator signaling by the SARSCoV-2 Spike protein
por: Caohuy, H., et al.
Publicado: (2022)

The Impact of COVID-19 on SARSCoV-2-Negative Elderly Patients with Hip Fractures: A Single-Center Retrospective Study from Shanghai, China
por: Zhao, Jinhui, et al.
Publicado: (2022)

Truncated ring-A amaryllidaceae alkaloid modulates the host cell integrated stress response, exhibiting antiviral activity to HSV-1 and SARSCoV-2
por: McNulty, James, et al.
Publicado: (2023)

Coupling of right ventricular function to pulmonary circulation as an independent predictor for non invasive ventilation failure in SARSCoV 2-related acute respiratory distress syndrome
por: Lazzeri, Chiara, et al.
Publicado: (2022)

Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia
por: Oltolini, Chiara, et al.
Publicado: (2023)

High concordance in SARSCoV-2 detection between automated (Abbott m2000) and manual (DaAn gene) RT-PCR systems: The EDCTP PERFECT-Study in Cameroon
por: Fainguem, Nadine Nguendjoung, et al.
Publicado: (2022)

1676MO Prevalence and clinical impact of asymptomatic or mildly symptomatic SARSCoV-2 infection among actively treated cancer patients during COVID-19 pandemic in Italy
por: Zambelli, A., et al.
Publicado: (2020)

Cohort profile: The UK COVID-19 Public Experiences (COPE) prospective longitudinal mixed-methods study of health and well-being during the SARSCoV2 coronavirus pandemic
por: Phillips, Rhiannon, et al.
Publicado: (2021)

Comportamiento de la infección SARSCoV-2 (COVID-19) en pacientes con diabetes mellitus tipo 2 en una unidad de cuidados respiratorios
por: Hernández-Solís, Alejandro, et al.
Publicado: (2023)

Pacientes con inmunización frente a SARSCoV-2 que han requerido ingreso hospitalario por neumonía COVID-19 en un hospital comarcal (Sierrallana-Cantabria)
por: Martínez, Paula Hernández, et al.
Publicado: (2022)

Corrigendum to “Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARSCoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study” [Life Sci. 253 (2020) 117592]
por: Elfiky, Abdo A.
Publicado: (2020)

Detection and Characterization of Influenza B Virus With Reduced Neuraminidase Susceptibility in a Stem Cell Transplant Recipient
por: Kodiyanplakkal, Rosy Priya L, et al.
Publicado: (2019)

Mapping the evolutionary landscape of Zika virus infection in immunocompromised mice
por: Johnson, Katherine E E, et al.
Publicado: (2020)

Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell–Depleted Stem Cell Transplantation
por: Chaekal, Ok-kyong, et al.
Publicado: (2022)

2695. Pneumocystis jirovecii Pneumonia in the Era of Effective Prophylaxis Following Hematopoietic Stem Cell Transplant
por: Drelick, Alexander Christian, et al.
Publicado: (2019)

Exogenous melatonin as potential adjuvant in anti-SarsCov2 vaccines
por: Maestroni, Georges
Publicado: (2020)

ASSOCIATION BETWEEN CARDIOVASCULAR COMORBIDITIES AND MORTALITY AMONGST SARSCOV-2 PATIENTS
por: Douen, Aaron, et al.
Publicado: (2022)

SARSCOV-2 vaccine associated with primary cutaneous peripheral T cell lymphoma
por: Montoya, VH Garcia, et al.
Publicado: (2022)

532. COVID-19 Pneumonia in Patients with Hematologic Malignancies – A Report from the US Epicenter
por: Plate, Markus, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sm1nh7kcvj312ollb98if9qpa2